Therapie des Morbus Behçet gestern und heute-Reference-Cited by-同舟云学术

Therapie des Morbus Behçet gestern und heute

Published:2012-06 Issue:6 Volume:109 Page:568-574
ISSN:0941-293X
Container-title:Der Ophthalmologe
language:de
Short-container-title:Ophthalmologe

Author:

Deuter C.M.E.,Zierhut M.,Doycheva D.,Kötter I.

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s00347-011-2504-9.pdf

Reference24 articles.

1. Arida A, Fragiadaki K, Giavri E, Sfikakis PP (2011) Anti-TNF agents for Behçet’s disease: analysis of published data on 369 patients. Semin Arthritis Rheum 41:61–70

2. BenEzra D, Cohen E, Chajek T et al (1988) Evaluation of conventional therapy versus cyclosporine A in Behçet’s syndrome. Transplant Proc 20:136–143

3. Buggage RR, Levy-Clarke G, Sen HN et al (2007) A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet’s disease. Ocul Immunol Inflamm 15:63–70

4. Deuter CME, Kötter I, Wallace GR et al (2008) Behçet’s disease: ocular effects and treatment. Prog Retin Eye Res 27:111–136

5. Deuter CME, Zierhut M, Möhle A et al (2010) Long-term remissions after cessation of interferon alpha treatment in patients with severe uveitis due to Behçet’s disease. Arthritis Rheum 62:2796–2805

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morbus Adamantiades-Behçet bei einer 29-jährigen Patientin;Spektrum der Augenheilkunde;2015-01-16

2. Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease;Autoimmune Diseases;2013